John Milligan
Vermögen: 2 Mio $ am 30.06.2026
Vermögen: 2 Mio $ am 30.06.2026
Dr. John F. Milligan ist Executive Chairman bei 4D Molecular Therapeutics, Inc. und Chairman bei Pacific Biosciences of California, Inc. Er ist Mitglied des Verwaltungsrats der Biotechnology Innovation Organization und der Ohio Wesleyan University. Dr. Milligan war zuvor als President bei Pharmasset, Inc. beschäftigt, als Director-Project Management bei Hoffmann-La Roche, Inc. und als President, Chief Executive Officer & Director bei Gilead Sciences, Inc. Er erhielt seinen Bachelor-Abschluss von der Ohio Wesleyan University und einen Doktortitel von der University of Illinois.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.06.2026 | 100.000 ( 0,19 % ) | 1 Mio $ | 30.06.2026 | |
| 03.06.2026 | 132.821 ( 0,04 % ) | 223 139 $ | 30.06.2026 | |
-.--% | 17.04.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Vorsitzender | 14.09.2020 |
| 4D MOLECULAR THERAPEUTICS, INC. | Vorsitzender | 01.08.2020 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | 22.07.2011 |
TurnCare, Inc.
TurnCare, Inc. Packaged SoftwareTechnology Services Develops unique technology that enhances skin and soft tissue circulation | Direktor/Vorstandsmitglied | 01.12.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| GILEAD SCIENCES, INC. | Vorstandsvorsitzender | 31.12.2018 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Präsident | - |
Ohio Wesleyan University
Ohio Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Vorsitzender | - |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures sequencing system products to help scientists to resolve genetically complex problems | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Ohio Wesleyan University
Ohio Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
TurnCare, Inc.
TurnCare, Inc. Packaged SoftwareTechnology Services Develops unique technology that enhances skin and soft tissue circulation | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen